Filter Results:
(610)
Show Results For
- All HBS Web
(610)
- People (4)
- News (110)
- Research (426)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
Show Results For
- All HBS Web
(610)
- People (4)
- News (110)
- Research (426)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
- 01 Mar 2012
- News
How to Close the Health Gap
real progress has been made over the last decade, thanks in part to funding from organizations such as the Bill & Melinda Gates Foundation and efforts by pharmaceutical companies and governments to make... View Details
- Profile
Thomas Grenier
biotech investments. "I showed that it was far more profitable in the United States and that U.S. companies are better at developing new drugs." Thomas will continue to explore health care in his summer internship with... View Details
- 01 Jan 2008
- News
Jeffrey R. Immelt, MBA 1982
protein biomarkers that have been identified as the precursor to Alzheimer’s disease. “There’s still no cure,” he observes, “but if you know that someone has the early signs of the disease and combine that with some of the new drugs the View Details
- 01 Oct 2008
- Research & Ideas
How Much Time Should CEOs Devote to Customers?
the current economic downturn, companies need marketing skills more than ever. But while every corporate mission statement pays lip service to respecting customer needs, actual customer expertise is typically a mile wide and an inch deep.... View Details
Keywords: by John Quelch
- 04 May 2010
- First Look
First Look: May 4
910-409 On July 5, 2004, Pfizer's China team received disappointing news. China's patent review board just invalidated the company's existing patent on one of its most successful drugs, Viagra. Making matters worse, a Guangdong-based View Details
Keywords: Martha Lagace
- 01 Dec 2003
- News
Alumni Luminaries Discuss Careers, Values with HBS Students
was evident in the questions put to a panel composed of this year's winners of the School’s highest honor, the Alumni Achievement Award. These distinguished graduates were selected for their contributions to their companies and... View Details
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
dubbed "a market for know-how." The new entrants became sellers; established pharmaceutical companies became buyers of the technology. This market for know-how reduced the barriers to entry.... View Details
- 01 Feb 2002
- News
Telling the Electronic Century's Unfinished Story
consumer electronics and computers (except for software) was nearly complete. A century before, the early architects of the consumer electronics path had been three competing industrial forces: the United States, Europe, and Japan. Today, in consumer electronics, only... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
heralding the start of National Biotechnology Month, as January 2000 had been designated by the U.S. Senate. For biotech, in fact, the party had begun months earlier, when hundreds of millions of dollars had poured into promising View Details
- 01 Jan 2004
- News
Donald P. Nielsen, MBA 1963
self-cleaning rat cages for psychology labs. Learning that pharmaceutical companies use large quantities of rats, they negotiated a deal with him and over the next few months also executed a roll-up strategy... View Details
- 24 Jul 2014
- Op-Ed
Reform Tax Law to Keep US Firms at Home
Editor's Note. Given a veritable flood over the last year of corporate "inversions"—US companies that reincoporate in other countries to take advantage of favorable tax rates and business regulations—lawmakers in Washington D.C.... View Details
- 01 Oct 2013
- First Look
First Look: October 1
yields-is believed to be an important factor contributing to the credit cycle. This paper analyses this phenomenon in the corporate bond market. Specifically, we show evidence for reaching for yield among insurance companies, the largest institutional holders of... View Details
Keywords: Sean Silverthorne
- 24 Aug 2020
- Blog Post
My Journey to Joining the first MS/MBA Biotechnology: Life Sciences Cohort
forecasting expected revenues, to developing an equity investing plan for a major pharmaceutical company and performing due diligence on M&A targets. I also spent four months on secondment within a... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
headlines, the vaccine sector was a pretty sleepy space. Interest in vaccine development and production had been on the decline for decades. In the 1960s—the triumphant years after Jonas Salk discovered the first polio vaccine—there were 26 View Details
- Profile
Rocio Parra
Why was getting a business education important to you? As a consultant, I had the opportunity to work in a variety of industries from pharmaceuticals and medical devices to government and consumer packaged goods. Through these... View Details
Keywords: Retail
- 23 Jul 2001
- Research & Ideas
How Relationships are Building Biotech
on biotech companies in terms of securing resources. And if the top executives had a career background at a pharmaceutical and/or healthcare company—the companies considered... View Details
Keywords: by Martha Lagace & Mallory Stark
- 01 Dec 2003
- Research & Ideas
Sometimes Success Begins at Failure
in history. Most firms act as if false negatives don't exist because they don't have processes for managing them. In their own industries, many companies might have missed similar opportunities. Although smart organizations have... View Details
- 01 Oct 1998
- News
Playing to Win
in turning losing teams into winners, Louis-Dreyfus has an enviable record of reshaping underperforming companies into formidable competitors. A scion of one of France's most prominent business families, he rejuvenated IMS International,... View Details
Keywords: Garry Emmons
- 01 Sep 2010
- News
Fair Trade
identity was, to the next stage. For a time, it seemed that this model would involve the reuniting of beauty and health. The world’s largest pharmaceutical companies purchased some of the most iconic brands... View Details
- Profile
Evan Rachlin
experienced as a medical student, business issues are an inescapable reality for any physician. While shadowing a pediatrician in private practice, he noticed the tension between the busy physician and a pharmaceutical representative... View Details